News for Industry

Using Stem Cells To Grow New Hair (Eureka Alert)

 

(La Jolla, CA) Pluripotent stem cells from as a new treatment for hair restoration.



BioTime Announces Issuance of 14 New Patents in the Fields of Regenerative Medicine, Stem Cell Technology, and Cancer Therapy (Digital Journal)

 

(Alameda, CA) BioTime In announcing the issuance of 14 new patents utilizing pluripotent stem cell technology for therapeutic applications in the field of regenerative medicine.



Orgenesis and Pall Corporation Receive $800,000 Grant From BIRD Foundation for Diabetes Research and Development (CNN)

 

(White Plains, NY) Orgenesis and PALL Corporation received an $800,000 grant from the Israel Binational Industrial Research and Development  (BIRD) Foundation for the development of functional insulin producing cells (IPCs is).



Regeneus Ltd Acne Treatment Patent Granted (ABN News Wire)

 

(Sydney, Australia) Patent granted to Company for the use of stem cell treatment for acne.



Scientist Patents Technology to Advance Stem Cell Therapeutics (Scicasts)

 

(Piscataway, NJ) A breakthrough in the area of gene expression for stem cell therapeutics.



Tengion Provides Clinical Update and Reports Third Quarter 2014 Financial Results and Cash Position (Globe News Wire)

 

(Winston-Salme, NC) Tengion Inc reported key clinical data and financial/operating results for the quarter ending on September 30, 2014.



UW-Madison Researchers Discover Method To Encourage Self-Renewal Of Stem Cells (Host Madison)

 

(Madison, WI) Eternal preservation of progenitor cells in the pluripotent stage.



Molecular Time Signaling Controls Stem Cells During Brain’s Development (Medical XPress)

 

(Stockholm, Sweden) Karolinska Institute researchers explain how stem cells in the brain change to allow the production of different cell types.

 



BioLife Solutions Named to Deloitte’s 2014 Technology Fast 500™ List of Fastest Growing Companies in North America (Market Watch)

 

(Bothell, WA) BioLife Solutions Incorporated is a leading developer, manufacturer and marketer of proprietary clinical grade cryopreservation freeze media was named to the Deloitte 2014 technology fast 500.